Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM Alliance. Innovation PRELIMINARY. Management

Transcription

1 OCTOBER 5-6, 2015 PARIS, FRANCE 6 th EDITION THE LEADING PARTNERING MEETING IN OPEN INNOVATION FOR LIFE SCIENCES CONFERENCES EXHIBITION HALL ONE-ON-ONE PARTNERING MEETINGS NETWORKING Open PRELIMINARY PROGRAM 2015 Strategic Innovation Alliance Management Market Investors' Access Forum E-Health AN EVENT BY

2 Innovation Days Presentation About the Innovation Days Innovation Days aims at connecting healthcare stakeholders and exploring new trends in Open Innovation through valuable discussions and debates. Industry stakeholders and CEO entrepreneurs, academics, key decision makers together with investors and practitioners in Intellectual Property and Technology Transfer will share best practices, know-how, and strategic orientations in the healthcare international marketplace. Those forums will be followed by Biotech company presentation tracks, identified as the most innovative projects from the Innovation Prize. Innovation Days is an essential event for partnering opportunities. Participants will maximize qualified alliances thanks to a cutting-edge partnering platform updated and modernized in In addition to productive partnering, Innovation Days offers interactive workshops, panels, company presentations, and a dedicated Innovation Gallery. Innovation Days Highlights Large networking opportunities Innovation prize awarding ceremony Interactive panels and workshops featuring experts from the biotech and pharma industry Keynote sessions with executives from biotech and pharma industry leading the way with insights into business analytics, regulatory, challenges and innovation strategy Biotech elevator pitch sessions with presentation from the most innovative companies in key therapeutic fields Who will you meet? Innovative biotech companies Academic researchers & Innovation Prize candidates Pharmaceutical companies Institutional representatives Clusters and bioparks Investors An overview of the Innovation Days participants 30 differents countries represented 68 speakers with conferences, workshops and presentations 15+ international posters in the in Innovation Gallery 40+ exhibitors in the exposition hall and the Innovation Gallery 6750 messages sent via the partnering platform 1070 partnering meetings

3 OUR LAUREATES DELIVER: PROOF OF QUALITY PROJECTS > 850 PROJECTS SUBMITTED SINCE FINALISTS PRESENT THEIR PROJECT EACH YEAR DEALS CONTRACTED AFTER INNOVATION PRIZE PARTICIPATION 2012 AICURIS 2013 MELLITECH 2013 IMMUNE THERAPY HOLDINGS 2014 DEEPCHEK HIV 2014 ITEOS THERAPEUTICS 2015 XL-PROTEIN

4 PRELIMINARY PROGRAM MONDAY, OCTOBER 5 th, :00-10:00 CONFERENCE REGISTRATION WELCOME COFFEE IN THE EXHIBIT HALL 10:00-10:30 OPENING BY UNIVERSAL MEDICA GROUP 10:30-12:00 KEYNOTE SESSION Strategic Alliances Management The high cost of R&D, risk management considerations as well as market demand, makes it increasingly attractive for industry players to form alliances, often in the form of licensing or co-marketing/co-promotion agreements. The resulting benefits of these alliances include: ALLIANCE MANAGEMENT For licensors, out-licensing maximizes the value of a compound while freeing the organization from many of the risks associated with manufacturing, providing services and establishing distribution channels For licensees, in-licensing can be very profitable by allowing companies to fill new product pipelines For co-marketers and co-promoters, the collaboration with marketing partners allows for broader distribution of products This plenary session is designed to walk you through the steps necessary to create a strong, sustainable and impactful Alliance Management Community of Practice. 12:00-13:30 LUNCH 13:30-14:30 PLENARY SESSION Major Deals Transactions for Pharma, Biotech and Healthcare The surge of biopharma mergers that dominated 2014 has continued into the new year INVESTOR The panelists in this session examine some of the significant deals of the last 12 months, including transactions they have been involved in, and what these deals reveal about pharma's priorities, strategy and the options available to drug development companies in need of a corporate partner. Join this session for a strategic look inside the deal.

5 PRELIMINARY PROGRAM MONDAY, OCTOBER 5 th, :30-15:15 WORKSHOP The tactics of closing funding deals This workshop is focused on delivering results and securing funding at All Levels: Boards, Angels, VCs, Corporate Partners and Other Sources of Funds. INVESTOR The tools of raising money and getting the deal done Delivering the perfect elevator pitch Pull and push campaigns Creating opportunities so good things can happen A scientific approach to "selling" Planning the funding campaign Creating appropriate roles for your team Utilizing the resources Bringing it home Term sheets, due diligence, drafting, negotiating Effective visuals as part of presentations Different audiences, different approaches 15:15-15:45 NETWORKING BREAK 15:45-18:00 UNIVERSAL BIOTECH INNOVATION PRIZE Awarding Ceremony Chairperson s Opening remarks COMPANIES PRESENTATION INNOVATION Innovation Prize: the best success stories 2015 Companies Presentation: the 5 finalists Awards 18:00-19:00 RECEPTION IN THE EXHIBIT HALL 19:00 END OF THE DAY

6 PRELIMINARY PROGRAM TUESDAY, OCTOBER 6 th, :30-09:30 CONFERENCE REGISTRATION WELCOME COFFEE IN THE EXHIBIT HALL 09:30-10:15 Social Media Monitoring for Pharma & Biotech DIGITAL For the healthcare industry, it is becoming increasingly important to be able to react quickly and decisively to events on social media. Additionally, companies are increasingly utilizing social media as a tool to build relationships with patients and the general public. Mid-sized, specialized and consumer care companies are leading the change from uni-directional broadcasting of information to an engaging and relationship-orientated online conversation. However, in general, the industry needs to become less risk averse to new engagements with stakeholders to remain relevant in the overall healthcare discussion. The increased engagement of regulators will drive further uptake of the digital channels by other stakeholders and demonstrate the importance of these channels to the overall healthcare ecosystem. Come and discover best practices in social media and new innovative tools for business intelligence. 10:15-11:00 Lessons in Mindful Communication From the Top Social Influencers in Biotech DIGITAL If you are a Pharmaceutical or Biotechnology company that has already or is considering launching a Facebook/Twitter/LinkedIn page, there are a few key items you must address to mitigate risk and satisfy your safety, medical, legal and regulatory departments. Join the session and discover key tips to boost your visibility. 11:00-11:30 NETWORKING BREAK 11:30-12:15 Marketing Your TTO s Technologies Via Social Media DIGITAL Tech transfer offices worldwide are seeing the benefit of integrating their promotional efforts for new technologies using a mix of traditional marketing channels, websites, professional networks, and social media platforms. The truth is, social media CAN AND DOES WORK, but it has to be used with skill, concerted effort, continuous assessment, and purposeful iteration. Join and know which platforms are best suited for your technologies, your core audience, and your ultimate goals. 12:15-14:00 LUNCH 14:00-16:00 Companies Presentation: discover the most innovative companies in e-health!

7 OCTOBER 5-6, 2015 PARIS, FRANCE 6 TH EDITION EVENT ORGANIZED BY SPONSORS CONTACT FOR INNOVATION DAYS Universal Medica Group 106, Bureaux de la Colline Saint-Cloud FRANCE +33 (1) PRELIMINARY PROGRAM 2014 Rafi Mardachti, President & CEO rafi.mardachti@universalmedica.com Contact for Conference Program: Aurélia Ringard, Business Developer aurelia.ringard@universalmedica.com +33 (1) Contact for Event Management: Quentin Vogel, Business Developer Project Manager quentin.vogel@universalmedica.com +33 (1)